Latest filing published 06 Oct 2021 for IRLAB Theraoeutics AB, €11k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Lena Torlegård: trading record in brief
Lena Torlegård discloses dealings in 2 companies, chiefly IRLAB Therapeutics AB and IRLAB Theraoeutics AB. The record holds 3 filings, for trades running from 5 September 2019 to 5 October 2021.
Every open-market trade on record is a purchase: 3 purchases worth €24k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2021 to date brings 1 purchase and no sales.
A typical purchase (the median) is worth €8,379.
The newest entry dates from 6 October 2021: an open-market purchase of €11k, in IRLAB Theraoeutics AB. The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for notifying a trade is three business days (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Lena Torlegård
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,573 shares@ SEK 43.35100.0% of flowAktieISIN SE0012675361FI:csv-09353e48045cecc13fd7Canonical exit: 3 Jan 2022 (T+90)
- 1,450 shares@ SEK 36.70AktieISIN SE0012675361FI:csv-2a81673ca2f6a93b9c69Canonical exit: 9 Dec 2019 (T+90)
- 2,800 shares@ SEK 32.00100.0% of flowAktieISIN SE0012675361FI:csv-69fc98283d4d21ec5fa0Canonical exit: 4 Dec 2019 (T+90)
3 of 3 declarations